Imunon, Inc.
IMNN· Nasdaq
Filed Mar 24, 2017 · 10-K · 83 days after period end · 0001437749-17-005235
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $125.00K | $125.00K | — |
| Net Income | -$5.40M | -$5.51M | -$6.46M | -$3.95M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 24, 2017 · 83 d after period end